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ABSTRACT
Aberrant DNA methylation at CpG dinucleotides can
result in epigenetic silencing of tumour suppressor
genes and represents one of the earliest events in
tumourigenesis. To date, however, high-throughput
tools that are capable of surveying the methylation
status of multiple gene promoters have been restric-
tedtoalimitednumberofcytosines.Here,wepresent
an oligonucleotide microarray that permits the par-
allel analysis of the methylation status of individual
cytosines, thus combining high throughput and
high resolution. The approach was used to study
the CpG island in the promoter region of the tum-
our suppressor gene p16
INK4A. In total, 876 oligonuc-
leotide probes of 21 nt in length were used to inspect
the methylation status of 53 CpG dinucleotides, pro-
ducing correct signals in colorectal cancer cell lines
as well as control samples with a defined methylation
status. The information was validated by established
alternative methods. The overall methylation pattern
was consistent for each cell line, while different bet-
ween them. At the level of individual cytosines, how-
ever,significantvariationsbetweenindividualcellsof
the same type were found, but also consistencies
across the panel of cancer cell lines were observed.
INTRODUCTION
In the human genome,  4% of the cytosine residues are modi-
ﬁed by methylation at their carbon-5 position. DNA methyla-
tion plays a key role in genomic imprinting, the maintenance
of genome integrity and has been implicated as an important
factor in the development of cancer (1–3). Alterations in the
epigenetic pattern are among the earliest and most common
events in tumourigenesis (4,5). Almost all methylation
takes place at CpG dinucleotide: a cytosine that is located
50 to a guanine (6). While this dinucleotide is generally under-
represented in the human genome sequence, there are local
regions—CpG islands—which are comparatively rich in
unmethylated CpG sites. More than 60% of all known human
genes contain CpG islands. Extensive methylation of these
sites frequently leads to gene silencing (7). Aberrant hyper-
methylation of CpG islands in cancer cells is responsible
for the transcriptional inactivation of many genes, including
tumour suppressor genes (4).
Several methods exist to detect changes in the DNA
methylation pattern. Most of these techniques use bisulﬁte
treatment to uncover the methylation status. Sodium bisulﬁte
induces methylation-dependent single nucleotide polymorph-
isms by converting unmethylated cytosine to uracil and, upon
PCR ampliﬁcation, to thymine. 5-methylcytosine is highly
resistant to sodium bisulﬁte treatment and thus becomes amp-
liﬁed as cytosine. The most common assay to detect DNA
methylation changes is methylation-speciﬁc PCR (MSP) (8).
Two primer sets—one speciﬁc for the C-containing sequence,
the other binding to T-containing DNA—are used to discrim-
inate between the methylated and unmethylated status of
genomic DNA. Also, the combined bisulﬁte restriction ana-
lysis (COBRA) (9), uses sodium bisulﬁte treatment, which is
followed by PCR-ampliﬁcation of the relevant regions, restric-
tion digestion and quantiﬁcation of the resulting restriction
fragments. Variation in methylation is indicated by the cre-
ation of new or the retention of pre-existing restriction sites.
Both methods examine only a very limited number of cyto-
sines and a single gene per assay. In contrast, sequencing of
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doi:10.1093/nar/gni072bisulﬁte-deaminated and PCR-ampliﬁed DNA (10) produces
results for every CpG in the region of interest. However, read
length is limited and the process is both cost- and time-
consuming.
As an alternative, oligonucleotide microarrays represent
a powerful tool for inexpensively generating a large amount
of information in a single experiment, while nevertheless
working at a single-base resolution. For the same reason,
microarrays are used in other genotyping assays (11).
Recently, microarrays were applied to study methylation in
leukaemias (12), Non-Hodgkin’s lymphoma (13) and gastric
tumour (14). The results provided evidence that deﬁned DNA
methylation proﬁles might represent an important character-
istic for tumour classiﬁcation (12). All these studies, however,
were limited by their restriction to a small number of CpG
dinucleotides in a few selected genes. Another array-based
approach indicated the potential for a genome-wide screening
of CpG islands in promoter regions (15). With this array, the
methylation scores of 276 anonymous CpG islands were ana-
lysed in a group of breast cancer cell lines. However, the
methylation status of deﬁned CpG dinucleotides could not
be determined.
To date, little was done to establish high throughput
methods that allow a detailed analysis of the DNA methyla-
tion pattern of individual CpG islands. Here, we present the
design, establishment and validation of a microarray system
that is capable of surveying the methylation status of multiple
CpGs individually. Oligonucleotide microarrays were pro-
duced by light-directed, mask-free in situ synthesis using
the Geniom One technology of febit AG (16). This array
format allows the ﬂexible production of oligonucleotide
arrays with probes for every CpG within genomic regions
of interest. We focussed our analysis on the p16
INK4A/
CDKN2A/INK4a tumour suppressor gene, which is located
in the chromosomal region 9p21 and encodes the cyclin-
dependent kinase inhibitor 2A. This gene is either deleted
or mutated in a wide range of cancers and was found to be
silenced by CpG methylation in manytumour types (17). After
hybridization of DNA samples from three colorectal cell lines
and analysing  29000 signals produced in each experiment,
the methylation status was deduced from the chip data and
independently validated with conventional techniques, docu-
menting the detailed resolution of the assay. From these stud-
ies, we could also deﬁne oligonucleotide probes that exhibited
an especially good ability to discriminate between methylated
and unmethylated DNA. Selection criteria could be deduced
from this information, which will translate into improved




The colon carcinoma cell lines HCT116, SW480 and SW48
were cultured under standard conditions. HCT116 cells
were grown in McCoy’s 5a medium (Invitrogen, Karlsruhe,
Germany) supplemented with 10% fetal calf serum (FCS),
while RPMI1640 medium (Invitrogen) supplemented with
10% FCS and 5% L-glutamine was used for SW480 and
SW48 cells.
DNA preparation
Genomic DNA was prepared from cells with the DNeasy
tissue kit of Qiagen (Hilden, Germany) according to the man-
ufacturer’s protocol and digested with EcoRI. An unmethyl-
ated control target was produced by PCR-amplifying genomic
DNA with forward primer d(AAACACGCCTTTGCTGG-
CAGG) and reverse primer d(CCACGCGCGTACAGATC-
TCT). A fully methylated target was generated by in vitro
methylation of 700 ng of the resulting PCR fragment with
8 U of SssI methylase (New England Biolabs, Frankfurt,
Germany) at 37 C for 2 h. Partially methylated targets were
generated by in vitro methylation with 8 U of bacterial methy-
lase M.HpaII or M.HhaI (New England Biolabs, Frankfurt,
Germany), respectively, at 37 C for 2 h. To determine the
methylation efﬁcacy, each template was digested with the
corresponding restriction enzyme, HpaII or HhaI (New
England Biolabs, Frankfurt, Germany), for 1 h at 37 C and
analysed by agarose gel electrophoresis.
Bisulfite treatment
DNA was treated with sodium bisulﬁte as described elsewhere
(10). In brief, 700 ng DNA was denatured in 50 ml of 0.2 mM
NaOH at 37 C for 20 min; 30 ml of freshly prepared 10 mM
hydroquinone (Sigma, Heidelberg, Germany) and 520 mlo f
3 M sodium bisulﬁte (Sigma) at pH 5 were added. Incubation
was under a layer of mineral oil at 55 C for 14 h. The DNA
was puriﬁed using the Gene Clean kit (Qbiogene, Heidelberg,
Germany) and eluted with 100 ml water. Finally, the DNA was
desulfonated by a 20 min treatment in 0.3 M NaOH at 37 C,
followed by an ethanol precipitation. The DNA pellet was
resuspended in 1 mM Tris–HCl, pH 8, and stored at  20 C.
Methylation-specific PCR (MSP) and combined
bisulfite restriction analysis (COBRA)
MSPwas performed as described previously (8). About 100 ng
of bisulﬁte-modiﬁed DNA was ampliﬁed with primer pairs
speciﬁc to unmethylated [U primer pair: d(TTATTAGAGG-
GTGGGGTGGATTGT), d(CAACCCCAAACCACAACCA-
TAA)] or methylated DNA sequences [M primer pair:
d(TTATTAGAGGGTGGGGCGGATCGC), d(GACCCCGA-
ACCGCGACCGTAA)], respectively. After an initial dena-
turation at 95 C for 3 min, DNA was ampliﬁed in 30 cycles
of 95 C for 30 s, 60 C (U primer pair) or 65 C (M primer pair)
for 30 s and 72 C for 45 s, followed by a ﬁnal extension at
72 C for 5 min. COBRA was performed according to a pre-
viously published protocol (9). In brief, sodium bisulﬁte-
treated DNA was PCR-ampliﬁed, digested with the restriction
enzyme BstUI (New England Biolabs) and separated on a
1.5% agarose gel.
Array design
In the analysis of 53 CpG dinucleotides of the p16 promoter
region, 252 control and 876 analysis probes were used. The
252 oligonucleotide probes acted as positive controls for the
occurrence of synthesis and hybridization or represented
entirely independent sequences, which indicated the back-
ground signal of unspeciﬁc binding. The analysis probe set
reﬂected the methylation status of every CpG dinucleotide. If
an oligonucleotide probe covered more than one CpG site,
probes for every possible combination of methylated and
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n CpG dinucleotides within a region covered by an oligomer
probe, there are 2
n different probe sequences. Additionally,
for every sense probe, the reverse complementary antisense
probe was generated. For an evaluation of reproducibility,
the analysis probe set was synthesized eight times on
each array. The sequences are available at www.dkfz.de/
funct_genome/epi-p16-oligos (and also as Supplementary
Data).
Array production
Oligonucleotide arrays were generated by photo-controlled
in situ synthesis as previously described (16) usingthe Geniom
One system and DNA processors provided by febit AG
(now available from febit biotech, Heidelberg, Germany).
Each DNA processor consists of four individually accessible
micro-channels, each of which is referred to as array in
this manuscript. Since in our analysis every array contained
Figure 1. StructureoftheanalysedCpGislandinthep16promoterregion.(A)TheDNAsequenceoftheCpGislandisshown.TheCpGdinucleotidesarenumbered
according to their position in the sequence. Because a longer sequence was used for the initial array design, numbering does not start at position 1. The binding
positions of the primers used in the MSP analysis are underlined. As an example for a sequence area covered by array-bound oligonucleotide probes, a 21mer
sequenceismarkedingrey,whichincludestheCpGdinucleotides784,788and791.(B)Designofoligonucleotideprobes.The16probesequencesareshown,which
were required to assay all possible combinations of methylated (M) and unmethylated (U) CpG dinucleotides in this 21mer sequence.
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oligonucleotides. They were synthesized in parallel in all
four arrays using standard DNA synthesis reagents (Proligo,
Hamburg, Germany) and 30-phosporamidites carrying a
50-photolabile group (18,19).
Labelling, hybridization and signal detection
For each hybridization, 50–100 ng PCR product was labelled
by random hexamer priming (20) in the presence of biotin-
dUTP (Roche, Mannheim, Germany). Prior to hybridization,
a prehybridization was performed in 100 mM 2-[N-morpho-
lino]ethanesulfonic acid (MES), 0.9 M NaCl, 20 mM
Na2EDTA, 0.01% (v/v) Tween-20, 1% BSA (Sigma) at
room temperature for 15 min. To each array, 5–10 ng/mlo f
biotin-labelled DNA were hybridized in the same buffer but
with only 0.5 mg/ml BSA and supplemented with 0.1 mg/ml
herring sperm DNA (Promega, Mannheim, Germany).
Hybridization was at 45 C for 3 h, followed by a ﬁrst washing
step at 25 C with 6· SSPE (0.9 M NaCl, 60 mM NaH2PO4,
pH 7.4 and 6 mM Na2EDTA) and a second washing step at
45 C with 0.5· SSPE supplemented with 0.005% (v/v) Triton
X-100. Fluorescence-staining was performed with 0.1 mg/ml
streptavidin-R-phycoerythrin-conjugate (Molecular Probes,
Leiden, The Netherlands) in 6· SSPE at 25 C for 15 min.
Subsequently, the arrays were rinsed with 6· SSPE at 25 C.
Signal detection was done using the internal CCD-camera
system of the Geniom One instrument. For detection of the
phycoerythrine chromophore, the Cy3 ﬁlter was employed.
The duration of signal integration was determined automatic-
ally by the instrument’s software. Typical integration times
were 350–500 ms.
Bisulfite sequencing
After bisulﬁte treatment as described above, PCR ampliﬁca-
tion was carried out in 20 ml Thermoprime polymerase and
ReddyMix reaction buffer (Abgene, Wiesenbach, Germany)
in the presence of 1.25 mM of each dNTP and 400 nM of
the primers d(CGTGGGGAGGAGTTTAGTTTTTTTT) and
d(CCTTAACTTCCCAAACCCCCAAAA). Aninitial incuba-
tion at 95 C for 3 min was followed by 30 cycles of 95 C for
30 s, 55 C for 30 s and 72 C for 45 s and a ﬁnal extension at
72 C for 5 min. The ampliﬁcation product was puriﬁed from a
1.5% agarose gel and cloned with the TA-TOPO Cloning kit
(Invitrogen). Sequencing on the plasmid DNA was performed
by GATC (Constance, Germany).
RESULTS
p16 methylation analysis by MSP and COBRA
For DNA methylation analysis, we used three colorectal can-
cer cell lines with different p16 methylation patterns. HCT116
cells have been shown to contain both an unmethylated and a
hypermethylated allele (21). In the SW 480 cell line, the pro-
moter of the p16 gene has been reported to be methylated (22),
while the p16 methylation status of SW48 cells has not been
published so far. In order to establish reliable conditions for
bisulﬁte deamination, we analysed p16 methylation by using
methylation-speciﬁc PCR (MSP) and combined bisulﬁte
restriction analysis (COBRA). Genomic DNA was treated
with sodium bisulﬁte, chemically introducing a C to T con-
version at unmethylated cytosines. For MSP, we used two
previously published primer pairs (8) that anneal to the posi-
tions of cytosines 738, 743, 745 and 854, 858, 860 and 871
(Figure 1). The results indicated that some copies of the p16
locus were methylated (M) and others unmethylated (U) in
HCT116 cells (Figure 2A). For SW480 cells, the MSP resulted
in a distinct M band, while for SW48 cells the gel showed a
prominent U band in addition to a weak M band (Figure 2A).
In vitro methylated and unmethylated templates exhibited
results that were consistent with the methylation status of
the respective templates (Figure 2A). For an independent
conﬁrmation of these results, we again deaminated genomic
DNA and analysed p16 methylation by COBRA (9). The res-
ulting PCR fragment was digested with BstUI, which cuts the
fragment only if the d(CGCG) target site had been retained
through bisulﬁte-mediated deamination. Enzymatic cleavage
thus indicates methylation, while lack of digestion indicates
absence of methylation. As expected, we observed a partial
digestion of the HCT116 amplicon (Figure 2B), which is in
agreement with the existence of both a hyper- and a hypo-
methylated p16 allele in HCT116 cells (21). In contrast, the
PCR amplicon generated from SW480 cells was completely
digested (Figure 2B), which is consistent with dense methyla-
tion (22). The SW48 amplicon was largely undigested
(Figure 2B) and was therefore considered to be predominantly
unmethylated. These results indicated substantial differences
Figure 2. p16 methylation analysis of genomic DNA from HCT116, SW480
and SW48 cells. (A) Methylation analysis by MSP. Two primer pairs were
applied that distinguish between methylated (M) and unmethylated (U) DNA.
In HCT116 cells, amplification occurred in both reactions, producing bands of
equal intensity. This is indicative for the existence of methylated (M) and
unmethylated (U) DNA in similar quantities. For SW480 cells, the MSP
resulted in an M band only. Analysis of material made from SW48 cells
exhibited a prominent U band and a much weaker M band. In vitro
methylated and unmethylated target samples were used as controls. (B)
Methylation analysis by COBRA. The restriction enzyme BstUI cleaves
d(CGCG) sequences while failing to cut d(TGTG) sites that result from
bisulfite conversion. Restriction patterns are shown that were obtained with
the 790 bp amplicon of the p16 promoter. Partial digestion was observed with
DNA of HCT116, indicating partial methylation. The PCR-fragment made
from SW480 cells was completely digested, which conforms to complete
methylation. Analysis of the SW48 material revealed only traces of the bands
that result from cleavage and can therefore be considered to be largely
unmethylated.
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thus established p16 as a stringent test locus for the establish-
ment of a methylation-sensitive oligonucleotide array.
p16 methylation analysis by oligonucleotide
microarrays
After having established the p16 methylation pattern by con-
ventional methods, we extended our analysis to 53 CpG dinuc-
leotides in the p16 promoter. For this purpose, we generated
oligonucleotide arrays on Geniom One DNA processors. For
each cell line, a biotinylated p16 amplicon was hybridized to
the ﬁrst of the four identical oligonucleotide arrays that are
present on a single DNA processor. Each array consisted of
7260 oligonucleotide probes, divided into 7008 analysis and
252 control probes, which represent positive controls for the
occurrence of DNA synthesis and hybridization or independ-
ent sequences for the measurement of background signal. The
latter probes reﬂected the methylation status of every CpG
dinucleotide in the sequence of the CpG island of the p16
promoter. If an oligonucleotide covered more than one CpG
site, probes for every possible combination of methylated and
unmethylated cytosines were generated. In addition to the cell
line sample, amplicons made from in vitro methylated or
unmethylated DNA were mixed as control samples with a
methylation level of 0%, 50% and 100%, respectively, and
hybridized individually to arrays 2, 3 and 4. The predicted
methylation level of these templates was conﬁrmed by bisul-
ﬁtesequencing,whichrevealed99%methylationoftheinvitro
methylated template and 0% methylation of the unmethy-
lated template (Figure 3A). After washing and staining with
ﬂuorescent dye, the signal intensities on all four arrays were
recorded. For each experiment, the background-corrected raw
data of array 1 was compared pairwise with the data obtained
on arrays 2, 3and 4. For each cell line, we observed the highest
correlation to the sample with the analogous methylation
level (Figure 3B). Also, there was a high degree of correlation
of the results obtained on either DNA strand (Figure 4A). To
determine the discrimination power of the array in greater
detail, we also methylated p16 PCR amplicons with site-
speciﬁc bacterial methylases (see Materials and Methods
for details). Oligonucleotide probes that cover individual
target sites were selected and the methylation level was
determined byarray hybridization, asdescribed above. Probes,
which interrogate exactly an individual methylated CpG site,
have shown in all cases signiﬁcantly higher signals in com-
parison with those probes containing one or more mismatches
(e.g. Figure 4B).
Selection of highly discriminative probe molecules
As could be expected, however, the individual oligonucleotide
probes differed in their performance. While many permitted
a good discrimination between methylated and unmethylated
DNA, others failed to provide conclusive data. Most of the
latter consisted of sequences that covered more than a single
CpG site. For those oligomers, discrimination between fully
methylated or completely unmethylated DNA was also good.
However, the occurrence of partial methylation in the target
sequence decreasedthe accuracy of the base calling(Figure 4).
For the selection of oligonucleotide probes that exhibit a high
discriminatory power, a calibration was performed for each
probe on the basis of the hybridizations with the control
samples of 0, 50 and 100% methylation. After calculating the
Figure 3. Establishment of a p16 methylation array. (A) Confirmation of the methylation status of in vitro-generated p16 templates by bisulfite sequencing.
A sequenceof 692 bp ofthe promoter regionincluding the CpG islandis shown.Filledsquares indicate methylatedcytosines,open squares representunmethylated
cytosines.FortheM.SssI-methylatedtemplate(M)99%(0.99)oftheCpGswerefoundtobemethylated,whiletheunmethylated(U)templateshowednomethylation
(0.00).(B)Pairwisecomparisonsofrawhybridizationdata.Eachdatapointinthescatterplotsrepresentsthesignalintensitiesobservedataparticularoligonucleotide
probe in the hybridizations of a cell line and a control sample. Left panel: amplicon of the cell line SW480 versus the in vitro methylated target DNA; the Pearson
coefficient is 0.88. Middle panel: cell line SW480 versus unmethylated target DNA; the Pearson coefficient is 0.27. Right panel: cell line HCT116, with 50% p16
methylation, versus an unmethylated target; a clear separation into signals of high and low correlation can be seen.
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tions, the intensity ratio M/(M+U) was computed for each
oligomer (23). In addition, the Pearson coefﬁcient of correla-
tion of the observed methylation level—measured from the
average signal intensities—to the expected methylation level
was computed. Only oligonucleotide probes that passed the
criteria of producing an intensity ratio of <0.2 for the 0%
methylated control target, a ratio of between 0.4 and 0.6 for
the 50% methylated target or >0.8 for the 100% methylated
target, and additionally exhibited a Pearson coefﬁcient of at
least 0.85 were selected for further analyses. More than one
halfoftheexaminedCpGdinucleotidesequencesinonestrand
were found to be covered by oligonucleotide probes, which
met both ﬁltering criteria. Overall, they showed an average
intensity ratio of 0.031 for the 0% methylated target, 0.494 for
the 50% methylated target and 0.934 for the 100% methylated
target (Figure 5). In this highly selective set, the number of
oligonucleotides that cover more than a single CpG site
increased to 100% from a percentage of 80% in the initial
probe set.
Detailed methylation analysis of genomic DNA from
colorectal cancer cell lines
Subsequently, the selected probes were used to analyse the
methylation level of the p16 promoter of the three colorectal
cell lines (Figure 6). In agreement with our previous results,
they exhibited a clear distinction at the methylation level.
Based on the microarray results, the CpG sites of the p16
amplicon from SW48 cells had a methylation level of 22%
(indicated by a mean intensity ratio of 0.220). For HCT116
cells, the methylation level was found to be 40% (mean intens-
ity ratio 0.397). The amplicon of SW480 cells, ﬁnally, exhib-
ited a mean intensity ratio of 0.653, corresponding to a
methylation level of  65%.
To conﬁrm the detailed methylation analysis by an inde-
pendent method, we subjected genomic DNA from HCT116,
SW480 and SW48 cell lines to bisulﬁte sequencing (Figure 7).
As predicted by the microarray analysis, the methylation status
Figure 5. Calibration data of 22 selected oligonucleotide probes. For every
oligonucleotide probe a calibration curve was recorded. Using the stringent
filter criteria mentioned in the text, probes were selected for the analysis of
methylation patterns, which could clearly discriminate among 0, 50 and 100%
methylation. For the best 22 probes selected, covering 54% of the CpG
positions, the diagram shows the intensity ratios and thus the measured
methylation levels obtained with DNA mixtures that represent 0, 50 and
100% methylation. Based on these results, the methylation degree of the
studied CpG positions could be accurately quantified.
Figure 4. Discrimination power of oligonucleotide probes. (A) Hybridization
ofafullymethylatedtarget.SignalintensitiesforprobesqueryingtheCpGsites
784, 788 and 791 are presented. Signals of the sense probes are shown in grey,
thesignalsontherelatedantisenseprobesinblack.Thesignalintensitiesforthe
MMMprobe(left-mostbars)exceedthesignalsfortheUUUprobes(right-most
bars) by a factor of 11. The signal intensities of the probes interrogating dif-
ferent variations of the methylation status vary considerably depending on the
position of the respective mismatch. (B) Hybridization of a site-specifically
methylated target.While the CpG on position 809 wasmethylated by using the
bacterial methylase M.HpaII, CpG sites 812 and 815 remained unmethylated.
The corresponding MUU probes exhibited a prominent, high signal (fourth
fromtheleft)whichexceedsthesignalfortheUMMprobes(fifth)byafactorof
65 and all other signals by a factor of at least 2.6.
Figure 6. Methylation analysis of the colorectal cancer cell lines. The results
of the 22 most discriminative probes are presented. The oligonucleotide
microarray assay detected clearly differential methylation between the
investigated cell lines SW48, HCT116 and SW480. On average, the p16
promoter exhibited a methylation level of 20% in SW48 cells, 40% in
HCT116 cells and 65% in SW480 cells.
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showed clear differences between the colorectal cancer cell
lines. HCT116 clearly exhibited a monoallelic methylation.
SW480 showed 92% methylation and SW48 only contained
 7% methylated cytosines.
DISCUSSION
We have described an oligonucleotide-based microarray
approach for a detailed analysis of the methylation status of
many individual CpG sites. Focusing on a CpG island in the
promoter of the tumour suppressor gene p16
INK4A, we demon-
strated that this technique provides signiﬁcant advantages over
previous array approaches. By using in situ synthesized oligo-
nucleotide microarrays made by the ﬂexible Geniom One
system, we were able to query individual CpG dinucleotides.
The inclusion of probes not only for the sense, but also for the
antisense strand of the DNA enlarged the number of accessible
CpG positions within the hybridization assay. Nevertheless,
there were differences in the performance of individual oligo-
nucleotides. The sequence composition of CpG islands has
a low complexity, which may compromise the speciﬁcity of
oligonucleotide probes. Consequently, the selection of probes
suitable for the analysis of DNA methylation patterns is a
crucial step. Owing to the very different sequence composition
of the oligonucleotide probes for the methylated and the
unmethylated status, the hybridization behaviour with respect
to melting temperature and hybridization kinetics may differ a
lot, especially for probes containing two or more CpG sites.
Cross-hybridization of a methylated target to probes speciﬁc
for the unmethylated status is more likely than vice versa. By
applying stringent ﬁlter criteria, we were able to select oligo-
nucleotide probes, which allow a reliable and reproducible
analysis of the methylation level of many individual CpG
sites. For sequences, which are more difﬁcult to be analysed,
individual oligomer probes are usually insufﬁcient for a proper
discrimination. In such cases, a tiling path of oligonucleotides
is required for producing statistically valid information.
Alternatively, dynamic allele-speciﬁc hybridization (24) or
enzymatic primer extension reactions (25) could improve
the analysis.
Consistent with published results (21), HCT116 cells usu-
ally had a monoallelic methylation of the p16 promoter region.
Most of the sequenced clones were either unmethylated or
completely methylated across the entire region that was ana-
lysed. However, some incompletely methylated alleles were
also observed. This result is in good agreement with an overall
methylation level of 40% observed with our microarray
experiments. The lower methylation of CpG site no. 10 in
Figure 7, as seen in the bisulﬁte data, was also found in the
microarray data, which provided an intensity ratio of 0.115 for
Figure 7. Validation of cytosine methylation patterns by genomic bisulfite sequencing. Genomic DNA was subjected to bisulfite sequencing. The sequences were
aligned to the corresponding regionof the genomicsequence ofp16 and the methylationstatus of all cytosine residues was determined. A sequenceof 692 bp of the
promoter region including the CpG island is shown. Filled squares indicate methylated cytosines, open squares represent unmethylated cytosines. The average
methylation level is presented on the right. Below, the average results derived from array-based analyses are shown for a representative region.
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adjacent CpG dinucleotides.
Our data also suggests that the p16 promoter is largely
unmethylated in SW48 cells. The microarray data, which res-
ulted in a methylation level of 20%, were validated not only by
MSP, which yielded a weak M band in addition to the prom-
inent U band, but also by COBRA, which produced some
faint bands of digested, therefore methylated DNA besides
the distinctive U band. In addition, the bisulﬁte sequencing
also showed a low level of methylation. The slightly lower
degree of methylation detected by MSP and COBRA com-
pared to the oligonucleotide microarray is probably due to
the fact that methylation analysis by MSP and COBRA is
restricted to a few cytosines in the 30 end of the primers.
Consistent with this notion, a closer analysis of our microarray
data revealed an intensity ratio of only 0.09 for the particular
CpG sites queried with both MSP and COBRA primers.
In agreement with published data (22), the CpG island of
p16 exhibited a clear hypermethylation in SW480 cells. While
MSP and COBRA as well as bisulﬁte sequencing showed a
high degree of methylation, the oligonucleotide microarray
displayed a methylation level of 65%. Again, both MSP
and COBRA analysed only a limited number of CpG sites,
which may not be representative for the whole CpG island.
The basic accuracy of the microarray assay had been con-
ﬁrmed in the calibration with the in vitro methylated samples.
Therefore, it is likely that the difference was introduced during
sample processing and preparation. The hybridization assay,
for example, directly analyses the mixture of molecules that
yield from the bisulﬁte conversion. In contrast, individual
molecules are being analysed by sequencing. Only a limited
degreeof redundancy isachieved therefore. Addingone ortwo
of the more mosaic clones, such as clone SW480.6 in Figure 7,
would change the average methylation value signiﬁcantly.
In addition, the sequenced fragments underwent cloning into
E.coli prior to the analysis. However, also the hybridization
assay might be biased by experimental factors. Since
sequences of alternating purines and pyrimidines have a pro-
found effect on the DNA structure, the sequence composition
of the CpG island is likely to inﬂuence the hybridization
efﬁciency.
In the analysis, several levels of variation were observed.
The overall methylation was clearly different between the
three colorectal cancer cell lines. However, also signiﬁcant
variations between individual cells of the same type were
found at the level of individual cytosines. Additionally, it is
apparent that particular cytosines within a CpG island can
have a distinct likelihood of being methylated. In all cell
lines, the cytosine no. 10 in Figure 7, for example, was sig-
niﬁcantly less frequently methylated than its neighbours.
Whether this is an effect of biological importance and how
it is regulated remains to be seen, but this will require large-
scale analyses of single-base resolution as presented here.
Importantly, this high-resolution determination of an indi-
vidual cytosine being differentially methylated cannot be
obtained by methylation-speciﬁc PCR and unlikely to be
detected by combined bisulﬁte restriction analysis.
In summary, our array provides a novel tool for high res-
olution DNA methylation analysis. The potential of this
method will be further expanded in future experiments, in
which we will include oligonucleotides from additional genes.
By multiplexing, using different dyes, and by reducing the
redundancy of each oligonucleotide well below 8-fold,
we will be able to analyse a lot more CpG sites per array.
Currently,weare intheprocessofestablishingachipfor 250
genes, which are correlated to prostate cancer on the level of
transcriptional variations. In addition, we intend to look at the
promoter region of all classical tumour suppressor genes. This
epigenetic array may eventually be used as a tool to monitor
therapeutical interventions before, during and after cancer
treatment. With DNA being a much more stable molecule
than RNA and with methylation variations occurring slower
than changes of the transcript level, epigenetic analyses might
be superior to other assays, such as transcriptional proﬁling,
sincethey are less prone to biases artiﬁcially introduced during
preparative steps. A comprehensive epigenetic array that
allows for a parallel analysis of several epigenetically regu-
lated cancer loci (26–28) may provide detailed insights into
the dynamic regulation of genomic DNA methylation and
represents a valuable diagnostic tool for oncological research.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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